CAR T-Cell Therapy Shows "Impressive" Results in Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 34
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2018 AND VI 8 AND IP 2
Results: 17
1
2
CAR T-Cell Therapy Makes Significant Inroads in Lymphoma: Kymriah and Yescarta Show Durable Remissions.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 32
- By:
- Publication type:
- Article
3
ASH Recaps "Phenomenal" Year for Acute Myeloid Leukemia Drug Approvals.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
4
The Challenges of Oral Cancer Drugs Use and Side-Effects Management.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 29
- By:
- Publication type:
- Article
5
Managing Adverse Events Linked to Immune Checkpoint Inhibitors: What Is Your Knowledge Level?
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 27
- By:
- Publication type:
- Article
6
Silent Patients Find Their Voices Through an Advocate's Journey.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 24
- By:
- Publication type:
- Article
7
Combining Immunotherapy and Radiotherapy Shows Good Synergy.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
8
Switching on the Light: A Model Immunotherapy Program for Oncology Practices.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 20
- By:
- Publication type:
- Article
9
CDK4/CDK6 Inhibitors Effective in Older Women, but Have More Side Effects.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
10
Dose-Dense Chemotherapy Should Be a New Standard in Early Breast Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 16
- Publication type:
- Article
11
Combining Pembrolizumab and Trastuzumab in Trastuzumab-Resistant HER2-Positive Breast Cancer Shows Promise.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 13
- Publication type:
- Article
12
Nab-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 13
- Publication type:
- Article
13
Extending Aromatase Inhibitor Therapy by 2 Years Better than 5 After Endocrine Therapy.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 12
- Publication type:
- Article
14
Authority Over Medical Practices—Something to Watch.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 7
- By:
- Publication type:
- Article
15
The Butterfly Effect: Improving the Chemotherapy Visit Experience.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 1
- By:
- Publication type:
- Article
16
New Breast Cancer Treatment Strategies Highlighted at SABCS 2017.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
17
A Dynamic FDA Has Led to More Rapid Cancer Drug Development.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 2, p. 1
- By:
- Publication type:
- Article